Finance

Lists
Why is 156100 down 15,72%?
Dive Deeper
156100:KOSDAQ
L&K Biomed Co Ltd
4 610,00 ₩
-15,72%
(-860,00) 1D
20 նոյ, 15:30:12 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 156100...
Open
5 260 ₩
High
5 370 ₩
Low
4 610 ₩
Mkt. cap
103,04 մլրդ
Avg. vol.
268,48 հզր
Volume
312,40 հզր
P/E ratio
46,68
52-wk high
16 400 ₩
52-wk low
2 730 ₩
EPS
99 ₩
Shares outstanding
22,35 մլն
No. of employees
105
Open
5 260 ₩
High
5 370 ₩
Low
4 610 ₩
Mkt. cap
103,04 մլրդ
Avg. vol.
268,48 հզր
Volume
312,40 հզր
P/E ratio
46,68
52-wk high
16 400 ₩
52-wk low
2 730 ₩
EPS
99 ₩
Shares outstanding
22,35 մլն
No. of employees
105
News stories
From web sources and news partners
About L&K Biomed Co Ltd
CEO-
Employees105
Founded2008
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
10,10 մլրդ
8,61 մլրդ
9,50 մլրդ
11,74 մլրդ
Cost of goods sold
1,77 մլրդ
1,68 մլրդ
1,36 մլրդ
1,95 մլրդ
Cost of revenue
1,77 մլրդ
1,68 մլրդ
1,36 մլրդ
1,95 մլրդ
Research and development expenses
767,44 մլն
395,34 մլն
466,02 մլն
483,70 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,65 մլրդ
6,60 մլրդ
6,97 մլրդ
7,38 մլրդ
Operating expense
7,99 մլրդ
8,13 մլրդ
8,22 մլրդ
8,51 մլրդ
Total operating expenses
9,76 մլրդ
9,81 մլրդ
9,57 մլրդ
10,46 մլրդ
Operating income
338,31 մլն
-1,20 մլրդ
-74,83 մլն
1,27 մլրդ
Other non operating income
109,34 մլն
-16,40 մլրդ
4,91 մլրդ
5,56 մլրդ
EBT including unusual items
2,16 մլրդ
-16,24 մլրդ
8,05 մլրդ
7,85 մլրդ
EBT excluding unusual items
2,16 մլրդ
-16,34 մլրդ
8,03 մլրդ
7,93 մլրդ
Income tax expense
-424,21 մլն
119,44 մլն
120,58 մլն
-128,91 մլն
Effective tax rate
-19,68%
-0,74%
1,50%
-1,64%
Other operating expenses
-
-
-
-
Net income
2,69 մլրդ
-15,82 մլրդ
8,33 մլրդ
7,57 մլրդ
Net profit margin
26,59%
-183,73%
87,66%
64,53%
Earnings per share
-
-
-
-
Interest and investment income
103,77 մլն
97,77 մլն
175,71 մլն
218,42 մլն
Interest expense
-779,99 մլն
-609,23 մլն
-816,88 մլն
-772,44 մլն
Net interest expenses
-676,22 մլն
-511,46 մլն
-641,17 մլն
-554,02 մլն
Depreciation and amortization charges
377,55 մլն
536,70 մլն
608,54 մլն
86,13 մլն
EBITDA
735,77 մլն
-527,26 մլն
621,74 մլն
2,37 մլրդ
Gain or loss from assets sale
-256,00 հզր
-61,29 մլն
-13,17 մլն
11,41 մլն
Upcoming events
AI content may include mistakes. Learn more
Google Apps